Beruflich Dokumente
Kultur Dokumente
Hilary P. Grocott
References
[1] Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004.CACancer J Clin 2004;54:8–29.
[2] Dulu A, Pastores SM, Park B, et al. Prevalence and mortality of acute lung injury andARDS
after lung resection. Chest 2006;130:73–8.
[3] Jansen JP, Brutel de la Riviere A, Alting MP, et al. Postpneumonectomy syndrome in adulthood.
Surgical correction using an expandable prosthesis. Chest 1992;101:1167–70.
[4] Kutlu CA, Williams EA, Evans TW, et al. Acute lung injury and acute respiratory distress
syndrome after pulmonary resection. Ann Thorac Surg 2000;69:376–80.
[5] Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy
pulmonary edema. J Cardiothorac Vasc Anesth 1995;9:442–51.
[6] van der Werff YD, van der Houwen HK, Heijmans PJ, et al. Postpneumonectomy pulmonary
edema. A retrospective analysis of incidence and possible risk factors. Chest 1997;
111:1278–84.
[7] WallerDA,Gebitekin C, SaundersNR, et al.Noncardiogenic pulmonary edemacomplicating
lung resection. Ann Thorac Surg 1993;55:140–3.
[8] Grichnik KP, D’Amico TA. Acute lung injury and acute respiratory distress syndrome after
pulmonary resection. Semin Cardiothorac Vasc Anesth 2004;8:317–34.
[9] Harpole DH Jr, DeCampMM Jr, Daley J, et al. Prognostic models of thirty-day mortality
and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 1999;117:969–79.
[10] Grichnik KP, Hill SE. The perioperative management of patients with severe emphysema.
J Cardiothorac Vasc Anesth 2003;17:364–87.
[11] Krasna MJ, Deshmukh S, McLaughlin JS. Complications of thoracoscopy. Ann Thorac
Surg 1996;61:1066–9.
[12] Atwell DM, Grichnik KP, NewmanMF, et al. Balance of proinflammatory and antiinflammatory
cytokines at thoracic cancer operation. Ann Thorac Surg 1998;66:1145–50.
[13] Williams EA, Quinlan GJ, Goldstraw P, et al. Postoperative lung injury and oxidative
damage in patients undergoing pulmonary resection. Eur Respir J 1998;11:1028–34.
[14] Lases EC, Duurkens VA, GerritsenWB, et al. Oxidative stress after lung resection therapy:
a pilot study. Chest 2000;117:999–1003.
[15] Zeldin RA, Normandin D, Landtwing D, et al. Postpneumonectomy pulmonary edema.
J Thorac Cardiovasc Surg 1984;87:359–65.
[16] Slinger PD. Postpneumonectomy pulmonary edema: good news, bad news. Anesthesiology
2006;105:2–5.
[17] Mathru M, Blakeman BP. Don’t drown the ‘‘down lung’’. Chest 1993;103:1644–5.
[18] Royer F, Martin DJ, Benchetrit G, et al. Increase in pulmonary capillary permeability in
dogs exposed to 100% O2. J Appl Physiol 1988;65:1140–6.
[19] Royston BD, Webster NR, Nunn JF. Time course of changes in lung permeability and
edema in the rat exposed to 100% oxygen. Am J Physiol 1990;69:1532–7.
[20] Szarek JL, Ramsay HL, Andringa A, et al. Time course of airway hyperresponsiveness and
remodeling induced by hyperoxia in rats. Am J Physiol 1995;269:L227–33.
[21] Witschi HR, Haschek WM, Klein-Szanto AJ, et al. Potentiation of diffuse lung damage by
oxygen: determining variables. Am Rev Respir Dis 1981;123:98–103.
[22] Williams EA, Evans TW, Goldstraw P. Acute lung injury following lung resection: is one
lung anaesthesia to blame? Thorax 1996;51:114–6
[23] Dean RT, Fu S, Stocker R, et al. Biochemistry and pathology of radical-mediated protein
oxidation. Biochem J 1997;324(Pt 1):1–18.
[24] Quinlan GJ, Evans TW, Gutteridge JM. Oxidative damage to plasma proteins in adult respiratory
distress syndrome. Free Radic Res 1994;20:289–98.
[25] Bonomi P, Faber LP, Warren W, et al. Postoperative bronchopulmonary complications in
stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy
and concurrent radiation. Semin Oncol 1997;24(4 Suppl 12):S12-123–9.
[26] Ginsberg RJ, Vokes EE, Raben A. Non-small cell lung cancer. In: DeVita VT, Hellman S,
Rosenberg SA, editors. Cancer: principles and practice in oncology. Philadelphia: Lippincott-
Raven; 1997. p. 887–99.
[27] Blum RH, Carter SK, Agre K. A clinical review of bleomycinda new antineoplastic agent.
Cancer 1973;31:903–14.
[28] Rabinowits M, Souhami L, Gil RA, et al. Increased pulmonary toxicity with bleomycin and
cisplatin chemotherapy combinations. Am J Clin Oncol 1990;13:132–8.
[29] Sleijfer S. Bleomycin-induced pneumonitis. Chest 2001;120:617–24.
[30] Siegenthaler MP, Pisters KM, Merriman KW, et al. Preoperative chemotherapy for lung
cancer does not increase surgical morbidity. Ann Thorac Surg 2001;71:1105–12.
[31] Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988.
Am J Infect Control 1988;16:128–40.
[32] The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as
compared with traditional tidal volumes for acute lung injury and the acute respiratory
distress syndrome. N Engl J Med 2000;342:1301–8.
[33] Takeda S, Funakoshi Y, Kadota Y, et al. Fall in diffusing capacity associated with induction
therapy for lung cancer: a predictor of postoperative complication? Ann Thorac Surg 2006;
82:232–6.
[34] Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference
on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am
J Respir Crit Care Med 1994;149:818–24.
[35] Ponn RB, LoCicero J III, Daly BDT. Surgical treatment of non-small cell lung cancer. In:
Shields TW, LoCicero J III, Ponn RB, et al, editors. General thoracic surgery. 6th edition.
Philadelphia: Lippincott, Williams & Wilkins; 2005.
[36] Fowler WC, Langer CJ, Curran WJ Jr, et al. Postoperative complications after combined
neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993;55:986–9.
[37] Roberts JR, Eustis C, Devore R, et al. Induction chemotherapy increases perioperative complications
in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg
2001;72:885–8.
[38] Martin J, Ginsberg RJ, Abolhoda A, et al. Morbidity and mortality after neoadjuvant
therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 2001;72:
1149–54.
[39] Stamatis G, Djuric D, Eberhardt W, et al. Postoperative morbidity and mortality after
induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated
patients. Eur J Cardiothorac Surg 2002;22:292–7.
[40] Leo F, Solli P, Spaggiari L, et al. Respiratory function changes after chemotherapy: an
additional risk for postoperative respiratory complications? Ann Thorac Surg 2004;77:
260–5.
[41] Greif R, Akca O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence
of surgical- wound infection. Outcomes Research Group. N Engl J Med 2000;342:161–7.
[42] Casati A, Fanelli G, Pietropaoli P, et al. Continuous monitoring of cerebral oxygen saturation
in elderly patients undergoing major abdominal surgery minimizes brain exposure to
potential hypoxia. Anesth Analg 2005;101:740–7